Back to Screener

Healthcare

Day One Biopharmaceuticals, Inc.(DAWN)

Live Price

Offline

$21.53

+0.00% today

Window Change

+232.25%

Window

Jun 23, 2025 โ†’ Apr 24, 2026

Market Cap
$2.22B
Revenue Growth
+20.6%
EPS Growth
-2.0%
Dividend Yield
0.0%
Partial coverage

Historical coverage is still expanding

This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.

Coverage: 212 bars ยท Jun 23, 2025 โ†’ Apr 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Day One Biopharmaceuticals, Inc. (DAWN) is a Healthcare stock with a market cap of $2.22B and listed on NASDAQ. The stock last traded around $21.53 and up 232.3% across the available one-year price window (Jun 23, 2025 โ†’ Apr 24, 2026). Baseline metrics include revenue growth of +20.6%, EPS growth of -2.0%, a dividend yield of 0.0%. What stands out right now is revenue +20.6%, EPS -2.0%, free cash flow -29.6% with operating margin -80.8% and ROIC -28.0%. Valuation already assumes a fairly strong business story at price/sales 14.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines DAWN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

DAWN

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

DAWN Max Drawdown

-23.55%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for DAWN and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 5, 26
โ€”
Est -0.31
โ€”
โ€”
Est 54350.2B
โ€”
May 5
โ€”
Feb 24, 26
โœ—
-0.20
Est -0.17
-17.6%
53712.0B
Est 49849.7B
+7.8%
Feb 24
โ€”
Nov 4, 25
โœ“
-0.19
Est -0.28
+31.8%
39795.0B
Est 38199.7B
+4.2%
Nov 4
โ€”
Aug 5, 25
โœ“
-0.29
Est -0.35
+17.1%
33908.0B
Est 39629.6B
-14.4%
Aug 5
โ€”
May 6, 25
โœ“
-0.35
Est -0.46
+23.9%
30761.0B
Est 36535.6B
-15.8%
May 6
โ€”
Feb 25, 25
โœ—
-0.69
Est -0.35
-97.1%
29208.0B
Est 30274.6B
-3.5%
Feb 25
โ€”
Oct 30, 24
โœ“
0.38
Est -0.41
+192.7%
93761.0B
Est 28484.2B
+229.2%
Oct 30
โ€”
Jul 30, 24
โœ“
-0.05
Est -0.67
+92.5%
8192.0B
Est 1026.3B
+698.3%
Jul 30
โ€”
May 6, 24
โœ—
-0.72
Est -0.67
-7.5%
โ€”
Est โ€”
โ€”
May 6
โ€”
Feb 26, 24
โœ—
-0.64
Est -0.57
-12.3%
560.0B
Est โ€”
โ€”
Feb 26
โ€”
Nov 6, 23
โœ“
-0.54
Est -0.60
+10.0%
โ€”
Est โ€”
โ€”
Nov 6
โ€”
Aug 7, 23
โœ—
-0.61
Est -0.60
-1.7%
โ€”
Est โ€”
โ€”
Aug 7
โ€”
May 1, 23
โœ“
-0.59
Est -0.60
+1.7%
โ€”
Est โ€”
โ€”
May 1
โ€”
Mar 6, 23
โœ“
-0.56
Est -0.57
+1.8%
โ€”
Est โ€”
โ€”
Mar 6
โ€”
Nov 7, 22
โ€”
-0.53
Est -0.53
0.0%
โ€”
Est โ€”
โ€”
Nov 7
โ€”
Aug 4, 22
โœ—
-0.60
Est -0.49
-22.4%
โ€”
Est โ€”
โ€”
Aug 4
โ€”
May 12, 22
โœ—
-0.48
Est -0.39
-23.1%
โ€”
Est โ€”
โ€”
May 12
โ€”
Mar 7, 22
โ€”
-0.36
Est -0.36
0.0%
โ€”
Est โ€”
โ€”
Mar 7
โ€”
Nov 8, 21
โœ—
-0.33
Est -0.28
-17.9%
โ€”
Est โ€”
โ€”
Nov 8
โ€”
Aug 10, 21
โœ—
-5.04
Est -0.31
-1525.8%
โ€”
Est โ€”
โ€”
Aug 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener